If your GLP-1 strategy is "we're cheaper," you're going to fail
So you're trying to scale your GLP-1 brand on Meta, and your biggest value is that you're cheaper than your competitors. If that's your strategy, chances are you're going to fail.
Competing on price is a race to the bottom
Competing on price is a race to the bottom. The real lever isn't cost — it's LTV.
46% of GLP-1 users quit within 5 months
A 2025 study found that 46% of GLP-1 users quit within five months, largely because of symptoms.
Helping customers manage symptoms extends LTV
Helping customers manage symptoms like nausea, digestive issues, and headaches can extend LTV by one to two months — and that changes your acquisition economics.
Compete on LTV, not price
Instead of trying to be the cheapest GLP-1 brand, maybe it's best to be the one that has the best LTV.